Carregant...
Antithrombotic therapy in peripheral artery disease: A review of the EUCLID trial results and current ongoing trials
In addition to risk‐factor modification, antithrombotic therapy is the hallmark of management to reduce cardiovascular ischemic events in patients with peripheral artery disease (PAD). Currently, the guidelines recommend long‐term antiplatelet therapy with aspirin or clopidogrel in this patient popu...
Guardat en:
| Publicat a: | Clin Cardiol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley Periodicals, Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6490002/ https://ncbi.nlm.nih.gov/pubmed/29355992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22839 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|